Vident Investment Advisory’s NEOPHOTONICS CORP NPTN Stock Holding History

Vident Investment Advisory’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22,302	Closed	-$351K	–	1379
2022 Q2	$351K	Sell	22,302 -3,306	-13%	-$50.5K	0.01%	955
2022 Q1	$389K	Buy	25,608 +372	+1%	+$5.67K	0.01%	1010
2021 Q4	$388K	Buy	25,236 +14,727	+140%	+$194K	0.01%	995
2021 Q3	$92K	Sell	10,509 -1,815	-15%	-$16.5K	﹤0.01%	1138
2021 Q2	$126K	Sell	12,324 -9,925	-45%	-$105K	﹤0.01%	1080
2021 Q1	$266K	Buy	+22,249	New	+$252K	0.01%	928

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Vident Investment Advisory's NPTN Position: Q3 2022 in Review

Vident Investment Advisory sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 22,302 shares — an estimated $351K sold.

Vident Investment Advisory first reported a position in NPTN in Q1 2021 and held it in 6 quarters. The position peaked at $389K in Q1 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Vident Investment Advisory reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Vident Investment Advisory sold 22,302 NEOPHOTONICS CORP shares in Q3 2022, an estimated $351K.
Vident Investment Advisory first reported a position in NEOPHOTONICS CORP in Q1 2021 and held it in 6 quarters.
Vident Investment Advisory's NEOPHOTONICS CORP position peaked at $389K in Q1 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Vident Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.